Phase Ib study of regorafenib (rego) and PF-03446962 (PF) in patients with refractory metastatic colorectal cancer (mCRC) (REGAL).
Conference Paper
Full Text
Duke Authors
- Blobe, Gerard Conrad
- Clarke, Jeffrey Melson
- Niedzwiecki, Donna
- Strickler, John
- Uronis, Hope Elizabeth
Cited Authors
- Clarke, JM; Blobe, GC; Strickler, JH; Uronis, HE; Zafar, Y; Morse, M; Dropkin, E; Howard, L; O'Neill, M; Rushing, CN; Niedzwiecki, D; Watson, H; Arrowood, C; Hurwitz, H
Published Date
- May 20, 2016
Published In
Volume / Issue
- 34 / 15_suppl
Start / End Page
- e15013 - e15013
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2016.34.15_suppl.e15013